The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 07, 2021
Filed:
Oct. 23, 2018
Applicant:
Emergex Vaccines Holding Ltd., Abingdon, GB;
Inventor:
Ramila Philip, Ivyland, PA (US);
Assignee:
Emergex Vaccines Holding Ltd., Abingdon, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/29 (2006.01); A61K 39/12 (2006.01); C07K 14/005 (2006.01); C07K 14/02 (2006.01); C12N 7/00 (2006.01); G01N 33/569 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/29 (2013.01); A61K 39/12 (2013.01); C07K 14/005 (2013.01); C07K 14/02 (2013.01); C12N 7/00 (2013.01); G01N 33/56972 (2013.01); G01N 33/56977 (2013.01); G01N 33/56994 (2013.01); A61K 2039/572 (2013.01); C12N 2730/10121 (2013.01); C12N 2730/10134 (2013.01); G01N 2333/02 (2013.01); G01N 2333/70539 (2013.01);
Abstract
The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of Hepatitis B virus (HBV) infection, and discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against HBV infection. The peptide and/or proteins of the invention may be used as a therapeutic drug to stimulate the immune system to recognize and eliminate HBV infection in infected cells or as a vaccine for the prevention of disease.